🔗 Share this article

The top legal official in Texas Ken Paxton is suing the producers of acetaminophen, claiming the corporations concealed potential risks that the drug created to pediatric neurological development.

The court filing follows a month after Donald Trump advocated an unsubstantiated connection between using Tylenol - alternatively called paracetamol - throughout gestation and autism spectrum disorder in offspring.

Paxton is filing suit against Johnson & Johnson, which once produced the medication, the sole analgesic approved for pregnant women, and the current manufacturer, which presently makes it.

In a official comment, he claimed they "betrayed America by making money from suffering and promoting medication ignoring the risks."

Kenvue says there is insufficient reliable data connecting Tylenol to autism.

"These manufacturers lied for decades, deliberately risking millions to boost earnings," Paxton, from the Republican party, declared.

The manufacturer stated officially that it was "very worried by the spread of false claims on the security of paracetamol and the possible consequences that could have on the well-being of American women and children."

On its official site, the company also stated it had "regularly reviewed the applicable studies and there is lacking reliable evidence that demonstrates a established connection between consuming acetaminophen and autism."

Groups representing physicians and health professionals concur.

The American College of Obstetricians and Gynecologists has said acetaminophen - the primary component in Tylenol - is a restricted selection for women during pregnancy to treat pain and fever, which can pose serious health risks if ignored.

"In multiple decades of studies on the use of acetaminophen in gestation, not a single reputable study has definitively established that the usage of paracetamol in any period of gestation causes neurological conditions in children," the association stated.

The court filing cites latest statements from the previous government in arguing the drug is allegedly unsafe.

Last month, the former president generated worry from medical authorities when he instructed women during pregnancy to "resist strongly" not to consume acetaminophen when sick.

The FDA then published an announcement that doctors should contemplate reducing the use of acetaminophen, while also declaring that "a direct connection" between the drug and autism spectrum disorder in children has not been proven.

Health Secretary Robert F Kennedy Jr, who supervises the FDA, had vowed in April to undertake "comprehensive study program" that would determine the origin of autism in a short period.

But experts cautioned that identifying a single cause of autism spectrum disorder - considered by experts to be the consequence of a complex mix of inherited and surrounding conditions - would prove challenging.

Autism is a category of enduring cognitive variation and condition that influences how individuals encounter and relate to the world, and is diagnosed using physician assessments.

In his legal document, Paxton - who supports Trump who is running for the Senate - asserts the manufacturer and Johnson & Johnson "willfully ignored and tried to quiet the research" around paracetamol and autism.

The lawsuit seeks to make the companies "remove any promotional materials" that states Tylenol is safe for expectant mothers.

This legal action mirrors the complaints of a collection of parents of minors with autism and ADHD who filed suit against the producers of Tylenol in recently.

The court dismissed the lawsuit, saying research from the parents' expert witnesses was lacking definitive proof.